Zafrens
Latest round
- Series A
Last raised
- Dec 2023
Total raised
- $41M
Investors
- 10
About Zafrens
Based in California, US, and founded in 2022, Zafrens Inc. operates as a biotechnology company that provides an experimental platform to study. In February 2025, Zafrens Inc.xpand. Zafrens develops an experimental platform that facilitates experiments while maintaining single-cell CITE-seq precision. The experiments are accomplished within the time and cost parameters equivalent to a conventional 96-well plate experiment. The platform is also able to generate insights and allows navigation across diverse therapeutic modalities.
Who invested in Zafrens
10 investors across 2 rounds
See all investors in Zafrens
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Zafrens
Who invested in Zafrens?
Zafrens has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Zafrens raised?
Zafrens has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Zafrens last raise money?
Zafrens's most recent round on record is a Series A, in Dec 2023.
What does Zafrens do?
Based in California, US, and founded in 2022, Zafrens Inc.
Where is Zafrens headquartered?
Zafrens is headquartered in San Diego, US.
Which VCs invest in companies like Zafrens?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Zafrens's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Zafrens? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.